Pharmacoeconomic considerations in the management of acute tumor lysis syndrome.
Farber
M S
MS
Department of Pharmacy Services, Detroit Medical Center, Detroit, MI 48201, USA.
D000208:Acute Disease; D000493:Allopurinol / Q000008:administration & dosage / Q000191:economics / Q000627:therapeutic use*; D000963:Antimetabolites / Q000008:administration & dosage / Q000191:economics / Q000627:therapeutic use*; D003362:Cost-Benefit Analysis; D006801:Humans; D015275:Tumor Lysis Syndrome / Q000188:drug therapy* / Q000191:economics / Q000517:prevention & control
D000963:Antimetabolites; D000493:Allopurinol